Rapport Therapeutics, Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$15.41(as of Aug 7, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Rapport Therapeutics, Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$15.41
Ticker SymbolRAPP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees69
CountyUSA
Market Cap$533.2M
EBIDTA-92.1M
10-Day Moving Average15.00
P/E Ratio-37.29
20-Day Moving Average15.01
Forward P/E Ratio0.00
50-Day Moving Average12.99
Earnings per Share-3.82
200-Day Moving Average14.78
Profit Margin-Infinity%
RSI58.37
Shares Outstanding36.5M
ATR1.41
52-Week High29.74
Volume328,951
52-Week Low6.43
Most Recent Support Level13.87
Book Value285.8M
Most Recent Resistance Level15.88
P/B Ratio10.40
Upper Keltner18.17
P/S RatioInfinity
Lower Keltner11.84
Debt-to-Equity Ratio18.17
Next Earnings DateUnknown
Cash Surplus48.2M
Next Ex-Dividend DateUnknown

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.

Rapport Therapeutics, Inc. Common Stock In Our Stock Scanner

As of Aug 08, 2025
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.